HUTCHMED (China) Limited (HCM)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

243.00p
   
  • Change Today:
      9.00p
  • 52 Week High: 325.00
  • 52 Week Low: 189.00
  • Currency: UK Pounds
  • Shares Issued: 872.11m
  • Volume: 18,300
  • Market Cap: £2,119.23m
  • RiskGrade: 226
  • Beta: 0.09

Latest ShareCast News

Hutchmed to get milestone payment after China drug approval

By Josh White

Date: Monday 30 Jun 2025

(Sharecast News) - Hutchmed announced on Monday that China's National Medical Products Administration (NMPA) has approved the new drug application for the combination of 'Orpathys'. Or savolitinib, and 'Tagrisso', or osimertinib, to treat patients with locally advanced or metastatic EGFR mutation-positive non-squamous non-small cell lung cancer (NSCLC) with MET amplification following progression on EGFR TKI therapy.

HCM Regulatory News

2025 Interim Results 07-Aug-2025 12:00 RNS
HUTCHMED to Announce 2025 Half-Year Results 03-Jul-2025 09:30 RNS
Update on Joint Corporate Brokers in London 02-Jul-2025 10:00 RNS
Blocklisting Six Monthly Return 30-Jun-2025 09:30 RNS
Total Voting Rights 30-Jun-2025 09:30 RNS

HCM News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HCM Market Data

Currency UK Pounds
Share Price 243.00p
Change Today 9.00p
% Change 3.85 %
52 Week High 325.00
52 Week Low 189.00
Volume 18,300
Shares Issued 872.11m
Market Cap £2,119.23m
Beta 0.09
RiskGrade 226

HCM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.48% below the market average43.48% below the market average43.48% below the market average43.48% below the market average43.48% below the market average
34.88% below the sector average34.88% below the sector average34.88% below the sector average34.88% below the sector average34.88% below the sector average
Price Trend
1.60% above the market average1.60% above the market average1.60% above the market average1.60% above the market average1.60% above the market average
51.11% above the sector average51.11% above the sector average51.11% above the sector average51.11% above the sector average51.11% above the sector average
Income Not Available
Growth
43.72% below the market average43.72% below the market average43.72% below the market average43.72% below the market average43.72% below the market average
86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average

HCM Dividends

No dividends found

Trades for 15-Aug-2025

Time Volume / Share Price
12:19 371 @ 236.71p
12:02 123 @ 242.00p
10:22 9 @ 243.00p
09:26 1,000 @ 242.88p
09:12 946 @ 235.00p

HCM Key Personnel

Chair Dan Eldar
CEO Weiguo Su

Top of Page